IP Library Granted Patent US 8,664,464
Granted Patent B2
US 8,664,464 · App. 10/538,427 · Granted Mar 4, 2014

Absorbent multilayer hydrogel wound dressings

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,664,464
App. No.
10/538,427
Granted
Mar 4, 2014
Kind
B2
Abstract

The invention provides wound dressings comprising an absorbent (porous) hydrogel composition comprising a foam portion which comprises a flexible plasticized hydrophilic polymer matrix having an internal cellular structure, and a continuous portion which comprises a flexible plasticized hydrophilic polymer matrix having relatively continuous internal structure. The continuous portion of the hydrogel composition includes apertures providing fluid flow communication through the continuous portion between an external surface of the continuous portion and the foam portion whereby the foam portion can take up external water or other fluid into the cellular structure through the apertures of the continuous portion. The continuous portion of the hydrogel composition may be tacky to the skin, allowing its use as a bioadhesive.

Claims (25)

1. A wound dressing comprising a hydrogel composition, said hydrogel composition comprising a first portion which comprises a flexible plasticized hydrophilic polymer matrix having an internal cellular structure, and a second portion which comprises a flexible plasticized hydrophilic polymer matrix having a relatively continuous internal structure, wherein the first and the second portion are of the same material, wherein an outward facing surface of the second portion is a skin-contactable surface, wherein the second portion of the hydrogel composition includes apertures providing fluid flow communication through the second portion between the skin-contactable surface of the second portion and the first portion, and wherein the apertures of the second portion of the hydrogel composition continue into the first portion of the composition to invade it, without penetrating it entirely, whereby the first portion and second portion of the hydrogel composition can take up external water or other fluid into the cellular structure through the apertures of the second portion and first portion.

2. A wound dressing according to claim 1 , wherein the dressing further comprises a backing layer over the hydrogel composition.

3. A wound dressing according to claim 2 , wherein the backing layer is substantially liquid-impermeable.

4. A wound dressing according to claim 3 , further comprising a layer of adhesive on the surface of the backing layer facing the hydrogel composition.

5. A wound dressing according to claim 4 , wherein the backing layer extends beyond at least one edge of the layer of hydrogel composition to provide an adhesive-coated margin adjacent to said edge for adhering the dressing to a surface.

6. A wound dressing according to claim 5 , further comprising at least one removable cover sheet to cover the wound facing surface of the hydrogel composition before use.

7. A wound dressing according to claim 6 , wherein the removable cover sheet provided with projections which extend into the apertures in the hydrogel composition.

8. A wound dressing according to claim 7 , wherein the projections extend only part way into the hydrogel sheet.

9. A wound dressing according to claim 1 , further comprising an absorbent layer for receiving fluid transmitted through said hydrogel composition.

10. A wound dressing according to claim 9 , wherein the absorbent layer comprises a further layer of hydrophilic foam.

11. A wound dressing according to claim 6 , which is sterile and packaged in a microorganism-impermeable container.

12. A wound dressing according to claim 1 , wherein the first portion of said hydrogel composition comprises a porous foam having an internal cellular structure such that the volume ratio of cell void to matrix is greater than about 1:3 and the second portion comprises a relatively non-porous matrix.

13. A wound dressing according to claim 1 , wherein one or both of the said portions of the hydrogel composition is adhered to the skin.

14. A wound dressing according to claim 1 , wherein the external surface of the said second portion of the hydrogel composition defines a wound contacting surface of the dressing.

15. A wound dressing according to claim 1 , wherein the absorption capacity of the hydrogel composition is between about 30% and about 10000%.

16. A wound dressing according to claim 1 , wherein the water uptake rate of the first portion of the hydrogel composition is at least about 2 μl/s as measured by the test method described herein.

17. A wound dressing according to claim 1 in the form of a sheet, wherein the sheet has a substantially uniform thickness of between about 0.5 to about 10 mm.

18. A wound dressing according to claim 1 , wherein the hydrogel composition has been obtained by a process which comprises polymerising a polymerisable mixture comprising a hydrophilic monomer, where the polymerisable mixture prior to polymerization comprises a first portion including a relatively high concentration of introduced gas bubbles and a second portion including a relatively low concentration of gas bubbles.

19. The wound dressing of claim 1 , wherein the apertures have a tapered shape with the wide end of the tapered shape at the skin contacting surface.

20. A method for dressing a wound or a burn, comprising covering the wound or burn with a dressing comprising a hydrogel composition comprising a first portion which comprises a flexible plasticized hydrophilic polymer matrix having an internal cellular structure, and a second portion which comprises a flexible plasticized hydrophilic polymer matrix having relatively continuous internal structure, wherein the first and second portion are of the same material, wherein an outward facing surface of said second portion is a skin-contactable surface, and wherein the said second portion of the hydrogel composition includes apertures providing fluid flow communication through the said second portion between the skin-contactable surface of the said second portion and the first portion, and wherein the apertures of the second portion of the hydrogel composition continue into the first portion of the composition to invade it, without penetrating it entirely, whereby the first and second portion of the hydrogel composition can take up external water or other fluid into the cellular structure through the apertures of the said first and second portion.

21. The wound dressing of claim 19 , wherein the apertures have a dimension at the skin contact surface of from 1 mm to 3 mm and a width at the top of the second hydrogen composition of 0.1 to 1 mm.

22. The wound dressing of claim 19 , wherein the angle of taper, measured from the perpendicular to the plane of the support sheet, is from 10 to 60 degrees.

23. The wound dressing of claim 19 , wherein the mean cross-sectional area of the apertures at their mid-point is from 10 to 25% of the total area of the central region of the first hydrophilic polymer.

24. The wound dressing of claim 19 , wherein the density of the apertures is from 10 to 100 per cm 2 .

25. The method for dressing a wound or a burn of claim 20 , wherein the apertures have a tapered shape with the wide end of the tapered shape at the skin contacting surface.

Assignments (18)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 6, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; TECHNIMOTION, LLC
Reel/Frame 050945/0278 →
RELEASE OF SECURITY INTEREST Recorded Oct 11, 2019
From: BANK OF AMERICA, N.A.
To: KCI USA, INC.
Reel/Frame 050710/0955 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
SECURITY AGREEMENT Recorded Feb 7, 2017
From: KCI USA, INC., AS GRANTOR
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 041650/0013 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
MERGER AND CHANGE OF NAME Recorded May 11, 2015
From: SYSTAGENIX WOUND MANAGEMENT (US),INC.; KCI USA, INC.
To: KCI USA, INC.
Reel/Frame 035645/0178 →
MERGER AND CHANGE OF NAME Recorded Feb 11, 2015
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.; KCI USA, INC.
To: KCI USA, INC.
Reel/Frame 034954/0870 →
SECURITY AGREEMENT Recorded Oct 29, 2013
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 031508/0011 →
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2013
From: J.P. MORGAN EUROPE LIMITED
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.
Reel/Frame 031506/0186 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2010
From: ETHICON, INC.; JOHNSON & JOHNSON; JOHNSON & JOHNSON MEDICAL LIMITED; JOHNSON & JOHNSON MEDICAL B.V.; JANSSEN PHARMACEUTICA N.V.; CILAG AG; CILAG HOLDING AG; JEVCO LIMITED
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.; SYSTAGENIX WOUND MANAGEMENT IP CO. B.V.
Reel/Frame 024563/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2010
From: JOHNSON & JOHNSON MEDICAL LIMITED
To: SYSTAGENIX WOUND MANAGEMENT IP CO. B.V.
Reel/Frame 024563/0265 →
SECURITY AGREEMENT Recorded Jan 30, 2009
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: J.P. MORGAN EUROPE LIMITED
Reel/Frame 022177/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2009
From: ETHICON, INC.; JOHNSON & JOHNSON MEDICAL LIMITED
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.
Reel/Frame 022071/0762 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2006
From: MUNRO, HUGH S.; SILCOCK, DEREK; BAYLIFF, SIMON W.; HOSKINS, RICHARD; GARCIA, SUSANA S.; BURGESS, HELEN; BARNES, JUSTIN
To: ETHICON, INC.
Reel/Frame 017412/0872 →